ImmunoCellular Therapeutics, Ltd. 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Mar 10, 2014
Insider Transaction Report
Form 4
Yu John S
DirectorSecretary
Transactions
- Award
Stock Option (right to buy)
2014-03-07+22,500→ 22,500 totalExercise: $1.34Exp: 2024-03-06→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over four years beginning April 7, 2014.